Literature DB >> 15530358

Estriol bound and ligand-free structures of sterol 14alpha-demethylase.

Larissa M Podust1, Liudmila V Yermalitskaya, Galina I Lepesheva, Vladimir N Podust, Enrique A Dalmasso, Michael R Waterman.   

Abstract

Sterol 14alpha-demethylases (CYP51) are essential enzymes in sterol biosynthesis in eukaryotes and drug targets in antifungal therapy. Here, we report CYP51 structures in ligand-free and estriol bound forms. Using estriol as a probe, we determined orientation of the substrate in the active site, elucidated protein contacts with the invariant 3beta-hydroxy group of a sterol, and identified F78 as a key discriminator between 4alpha-methylated and 4alpha,beta-dimethylated substrates. Analysis of CYP51 dynamics revealed that the C helix undergoes helix-coil transition upon binding and dissociation of a ligand. Loss of helical structure of the C helix in the ligand-free form results in an unprecedented opening of the substrate binding site. Upon binding of estriol, the BC loop loses contacts with molecular surface and tends to adopt a closed conformation. A mechanism for azole resistance in the yeast pathogen Candida albicans associated with mutations in the ERG11 gene encoding CYP51 is suggested based on CYP51 protein dynamics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530358     DOI: 10.1016/j.str.2004.08.009

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  30 in total

1.  Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?

Authors:  Karin Schleinkofer; Peter J Winn; Susanne K Lüdemann; Rebecca C Wade
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

2.  Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding.

Authors:  Chunquan Sheng; Zhenyuan Miao; Haitao Ji; Jianzhong Yao; Wenya Wang; Xiaoying Che; Guoqiang Dong; Jiaguo Lü; Wei Guo; Wannian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

3.  Comparative docking studies of CYP1b1 and its PCG-associated mutant forms.

Authors:  Malkaram Sridhar Achary; Hampapathalu Adimurthy Nagarajam
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

Review 4.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

5.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

6.  P450cam visits an open conformation in the absence of substrate.

Authors:  Young-Tae Lee; Richard F Wilson; Igor Rupniewski; David B Goodin
Journal:  Biochemistry       Date:  2010-04-27       Impact factor: 3.162

7.  Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives.

Authors:  Debora F Vieira; Jun Yong Choi; William R Roush; Larissa M Podust
Journal:  Chembiochem       Date:  2014-04-25       Impact factor: 3.164

8.  Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.

Authors:  Lian-Hua Xu; Shinya Fushinobu; Haruo Ikeda; Takayoshi Wakagi; Hirofumi Shoun
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

9.  The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.

Authors:  Oliver Hucke; Michael H Gelb; Christophe L M J Verlinde; Frederick S Buckner
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

10.  Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.

Authors:  Kirsty J McLean; Paul Carroll; D Geraint Lewis; Adrian J Dunford; Harriet E Seward; Rajasekhar Neeli; Myles R Cheesman; Laurent Marsollier; Philip Douglas; W Ewen Smith; Ida Rosenkrands; Stewart T Cole; David Leys; Tanya Parish; Andrew W Munro
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.